Gilead to End Coronavirus Drug Trials, Adding to Access Worry: Researchers

Preliminary results from a trial conducted by the US National Institutes of Health showed that Remdesivir cut hospital stays by 31% compared to a placebo.

from Top Business News- News18.com https://ift.tt/3dUnO2v
via IFTTT